Citation Impact
Citing Papers
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules
2016 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
1989 Standout
Cooperative Inhibition of Renal Cancer Growth by Anti-Epidermal Growth Factor Receptor Antibody and Protein Kinase A Antisense Oligonucleotide
1998
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
2005 Standout
Pomegranate and its Many Functional Components as Related to Human Health: A Review
2010 Standout
Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias
1995
Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1)
1999
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Dietary Intake and Bioavailability of Polyphenols
2000 Standout
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Dietary Polyphenols and the Prevention of Diseases
2005 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex
2000 Standout
In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice
2005 Standout
Bhc‐cNMPs as either Water‐Soluble or Membrane‐Permeant Photoreleasable Cyclic Nucleotides for both One‐ and Two‐Photon Excitation
2004 StandoutNobel
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Structure-activity relationships of VP-16 analogues
1994
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: Comparison of cyclic AMP-dependent and -independent cell cycles
1996 StandoutNobel
Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity
2000
Circadian rhythms and cancer chemotherapy
1995
Suppression of malignancy targeting the intracellular signal transducing proteins of cAMP: The use of site-selective cAMP analogs, antisense strategy, and gene transfer
1991
Polyphenols: food sources and bioavailability
2004 Standout
MAPK signal pathways in the regulation of cell proliferation in mammalian cells
2002 Standout
Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation
2002 Standout
How were new medicines discovered?
2011 Standout
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Cyclic nucleotide analogs as biochemical tools and prospective drugs
2000
Potential Impact of Strawberries on Human Health: A Review of the Science
2004 Standout
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.
1992 Standout
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
2014 StandoutNobel
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Nerve Growth Factor-stimulated B-Raf Catalytic Activity Is Refractory to Inhibition by cAMP-dependent Protein Kinase
1999
The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway
2005 Standout
Multiple Facets of the Modulation of Growth by cAMP
1995
Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome
1991 Standout
Regulatory Approvals of Pediatric Oncology Drugs: Previous Experience and New Initiatives
2003
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group
1990
Ellagitannins - nature, occurrence and dietary burden
2000
Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine
1993
Redox‐Active Catechol‐Functionalized Molecular Rods: Suitable Protection Groups and Single‐Molecule Transport Investigations
2007 StandoutNobel
Intensive Retreatment of Childhood Acute Lymphoblastic Leukemia in First Bone Marrow Relapse
1986
Conditional Glycosylation in Eukaryotic Cells Using a Biocompatible Chemical Inducer of Dimerization
2008 StandoutNobel
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health
2011 Standout
Criteria for Analyzing Interactions between Biologically Active Agents
1981
Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
1989
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences
1985 StandoutNatureNobel
Extended-Connectivity Fingerprints
2010 Standout
Biochemical Pathways of Caspase Activation During Apoptosis
1999 Standout
Amide bond formation and peptide coupling
2005 Standout
Insertion of an intracisternal A particle within the 5'-regulatory region of a gene encoding folate-binding protein in L1210 leukemia cells in response to low folate selection. Association with increased protein expression.
1992 StandoutNobel
Phenolic compounds and related enzymes as determinants of quality in fruits and vegetables
2001 Standout
Electrochemical study of catechols in the presence of 4,6-dihydroxy-2-methylpyrimidine
2005
Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.
1987
Mechanisms for T-cell selective cytotoxicity of arabinosylguanine
2003
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Efficient Pd(0)-catalyzed synthesis of 1,2,3-triazolo-3′-deoxycarbanucleosides and their analogues
2005
Bone Marrow Transplant
1990 Standout
Circadian Timing in Cancer Treatments
2010
Serotherapy of acute lymphoblastic leukemia with monoclonal antibody
1981
Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).
1982
A Convenient Preparation of Heteroaryl Sulfonamides and Sulfonyl Fluorides from Heteroaryl Thiols
2006
VP-16-213 (etoposide): The mandrake root from Issyk-Kul
1982
Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase.
1988
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods
1998
A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases
1998 Standout
Inhibition of the Raf-1 Kinase by Cyclic AMP Agonists Causes Apoptosis of v-abl-Transformed Cells
1997
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Extracellular protein kinase A as a cancer biomarker: Its expression by tumor cells and reversal by a myristate-lacking Cα and RIIβ subunit overexpression
2000
C-Terminally modified peptides via cleavage of the HMBA linker by O-, N- or S-nucleophiles
2016 StandoutNobel
Works of Thomas L. Avery being referenced
Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
1978
Site-Selective Cyclic AMP Analogs as New Biological Tools in Growth Control, Differentiation, and Proto-oncogene Regulation
1989
Analysis of the in vitro antitumor activity of novel purine-6-sulfenamide, -sulfinamide, and -sulfonamide nucleosides and certain related compounds using a computer-aided receptor modeling procedure
1991
Synthesis and antitumor evaluation in mice of certain 7-deazapurine (pyrrolo[2,3-d]pyrimidine) and 3-deazapurine (imidazo[4,5-c]pyridine) nucleosides structurally related to sulfenosine, sulfinosine, and sulfonosine
1990
Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210
1974
Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia
1980
Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213
1975
Chemotherapeutic characterization in mice of 2-amino-9-beta-D-ribofuranosylpurine-6-sulfinamide (sulfinosine), a novel purine nucleoside with unique antitumor properties.
1990
VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia
1980
Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
1988
4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.
1975
Synthesis and In Vivo antitumor and antiviral activities of 2′‐deoxyribofuranosyl and arabinofuranosyl nucleosides of certain purine‐6‐sulfenamides, sulfinamides and sulfonamides
1990
Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice.
1989
Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate
1990
Circadian dependence of host and tumor responses to cyclophosphamide in mice
1978
Vm‐26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia
1982
Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
1986